These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21577032)

  • 21. Angiokeratoma corporis diffusum in a patient with Hodgkin lymphoma: a new paraneoplastic skin manifestation?
    Han F; Wang P; Li Z; Zheng JH; Wang Q; Xu AE; Wang ZM
    Br J Dermatol; 2013 Jun; 168(6):1351-3. PubMed ID: 23278357
    [No Abstract]   [Full Text] [Related]  

  • 22. Chemotherapy alone for early-stage Hodgkin's lymphoma.
    Straus DJ
    N Engl J Med; 2012 Feb; 366(5):470-1. PubMed ID: 22149920
    [No Abstract]   [Full Text] [Related]  

  • 23. Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial.
    Engert A; Franklin J; Eich HT; Brillant C; Sehlen S; Cartoni C; Herrmann R; Pfreundschuh M; Sieber M; Tesch H; Franke A; Koch P; de Wit M; Paulus U; Hasenclever D; Loeffler M; Müller RP; Müller-Hermelink HK; Dühmke E; Diehl V
    J Clin Oncol; 2007 Aug; 25(23):3495-502. PubMed ID: 17606976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Third-line salvage chemotherapy in Hodgkin's disease.
    Bonadonna G; Viviani S; Valagussa P; Bonfante V; Santoro A
    Semin Oncol; 1985 Mar; 12(1 Suppl 2):23-5. PubMed ID: 2579440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central nervous system Hodgkin lymphoma developing during systemic chemotherapy.
    Burrows SH; Mannari D
    Br J Haematol; 2016 Jan; 172(2):156. PubMed ID: 26455346
    [No Abstract]   [Full Text] [Related]  

  • 26. Childhood Hodgkin disease treated with COPP/ABV hybrid chemotherapy: a progress report.
    Sagar TG; Chandra A; Raman SG
    Med Pediatr Oncol; 2003 Jan; 40(1):66-9. PubMed ID: 12426693
    [No Abstract]   [Full Text] [Related]  

  • 27. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
    Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
    J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A sinister itch: prurigo nodularis in Hodgkin lymphoma.
    Seshadri P; Rajan SJ; George IA; George R
    J Assoc Physicians India; 2009 Oct; 57():715-6. PubMed ID: 20329432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.
    Chronowski GM; Wilder RB; Tucker SL; Ha CS; Sarris AH; Hagemeister FB; Barista I; Hess MA; Cabanillas F; Cox JD
    Cancer; 2002 Dec; 95(12):2534-8. PubMed ID: 12467067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility and efficacy of dose-dense and dose-intense ABVD for high-risk patients with advanced Hodgkin lymphoma.
    D'Arco AM; Califano C; Barone L; Belsito Petrizzi V; Iovino V; Langella M; Maglione V; Rivellini F; De Lorenzo S
    Br J Haematol; 2015 Nov; 171(4):662-5. PubMed ID: 25873239
    [No Abstract]   [Full Text] [Related]  

  • 31. Controversies in the treatment of early-stage Hodgkin's lymphoma.
    Longo DL; Armitage JO
    N Engl J Med; 2015 Apr; 372(17):1667-9. PubMed ID: 25901431
    [No Abstract]   [Full Text] [Related]  

  • 32. FDG-PET in bleomycin-induced pneumonitis following ABVD chemotherapy for Hodgkin's disease--a useful tool for monitoring pulmonary toxicity and disease activity.
    Buchler T; Bomanji J; Lee SM
    Haematologica; 2007 Nov; 92(11):e120-1. PubMed ID: 18024389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pediatric Hodgkin's disease.
    Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM
    J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current role and future developments of radiotherapy in early-stage favourable Hodgkin's lymphoma.
    Eich HT; Müller RP
    Strahlenther Onkol; 2007 Dec; 183 Spec No 2():16-8. PubMed ID: 18167000
    [No Abstract]   [Full Text] [Related]  

  • 35. [Contribution of anthracyclines in treatment of lymphoproliferative disorders].
    Coiffier B
    Pathol Biol (Paris); 1987 Jan; 35(1):75-8. PubMed ID: 2436132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vanishing bile duct syndrome occurring after high-dose chemotherapy and autologous peripheral stem cell transplantation in a patient with Hodgkin's disease.
    Kömürcü S; Ozet A; Altundag MK; Arpaci F; Oztürk B; Celasun B; Tezcan Y
    Ann Hematol; 2002 Jan; 81(1):57-8. PubMed ID: 11807639
    [No Abstract]   [Full Text] [Related]  

  • 37. Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease.
    Piga A; Ambrosetti A; Todeschini G; Cetto G; Perona G; Cellerino R
    Cancer Treat Rep; 1984; 68(7-8):947-51. PubMed ID: 6204754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two Cases of Successful Autologous Hematopoietic Stem Cell Harvest after Treatment with Brentuximab Vedotin.
    Kojima M; Ogiya D; Kawai H; Miyamoto M; Ohmachi K; Ogawa Y; Nakamura N; Ando K
    Acta Haematol; 2015; 134(3):181-2. PubMed ID: 26022650
    [No Abstract]   [Full Text] [Related]  

  • 39. Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group.
    Meyer RM; Gospodarowicz MK; Connors JM; Pearcey RG; Bezjak A; Wells WA; Burns BF; Winter JN; Horning SJ; Dar AR; Djurfeldt MS; Ding K; Shepherd LE; ;
    J Clin Oncol; 2005 Jul; 23(21):4634-42. PubMed ID: 15837968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rituximab plus ABVD in newly diagnosed nodular lymphocyte-predominant Hodgkin lymphoma.
    Cencini E; Fabbri A; Bocchia M
    Br J Haematol; 2017 Mar; 176(5):831-833. PubMed ID: 26913966
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.